Cusaj D. Thomas

Cusaj Thomas is an associate in the firm’s Business Law department and a member of its Private Equity Group. He advises private equity sponsors, strategic investors and their portfolio companies on complex business transactions across a wide range of industries. His practice spans domestic and cross-border mergers and acquisitions, leveraged buyouts, continuation vehicle secondary transactions, minority and growth equity investments and general corporate representation.

Cusaj also works extensively with early-stage technology and life sciences companies, as well as search fund entrepreneurs, guiding them through fundraises, strategic investments and operational milestones. With experience representing both investors and companies, he brings a balanced perspective to structuring deals and mitigating risk. He joined Goodwin as a law clerk in 2018 and as an associate in 2019.

Cusaj’s representative experience includes advising:

• Cano Health LLC on its definitive merger agreement with special purpose acquisition company Jaws Acquisition Corp.
• Gandeeva in its $40 million Series A financing
• Biocon Biologics Ltd. on its definitive agreement to acquire Viatris Inc.’s global biosimilars business
• York Capital Management on its definitive agreement to acquire Comprehensive Rehab Consultants and affiliates
• 1686 Partners on its investment in MSCHF Product Studio Inc.
• TriSpan on its single-asset continuation vehicle for NAYA

Cusaj was a law clerk in Goodwin’s Private Equity group in 2018-2019 and a summer associate in 2017.

He interned with PepsiCo in its Frito-Lay headquarters during the summer of 2018, focusing on strategic finance.

• Quoted, “Becoming a Private Equity Lawyer | Goodwin Edition,” Chambers Associate, August 2025